Beyond vasomotor symptoms: reframing musculoskeletal health in the Women's Health Strategy.

Massen GM, Borra C, Hirst JE, Watt FE, Ferreira ML

Open source

DOI
10.1016/s2665-9913(26)00260-2
Published
2026 Sep 15
Container
The Lancet. Rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2665-9913-26-00260-2,
  title = {Beyond vasomotor symptoms: reframing musculoskeletal health in the Women's Health Strategy.},
  author = {Massen GM and Borra C and Hirst JE and Watt FE and Ferreira ML},
  year = {2026},
  journal = {The Lancet. Rheumatology},
  doi = {10.1016/s2665-9913(26)00260-2},
  url = {https://doi.org/10.1016/s2665-9913(26)00260-2}
}

RIS

TY  - JOUR
TI  - Beyond vasomotor symptoms: reframing musculoskeletal health in the Women's Health Strategy.
AU  - Massen GM
AU  - Borra C
AU  - Hirst JE
AU  - Watt FE
AU  - Ferreira ML
PY  - 2026
JO  - The Lancet. Rheumatology
DO  - 10.1016/s2665-9913(26)00260-2
UR  - https://doi.org/10.1016/s2665-9913(26)00260-2
ER  - 

APA

GM, M., C, B., JE, H., FE, W., & ML, F. (2026). Beyond vasomotor symptoms: reframing musculoskeletal health in the Women's Health Strategy.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(26)00260-2

Source records